Sign in

CIK 0001703057 · Large accelerated filer

AbCellera Biologics Inc.

Sign in to watch
Ticker
ABCL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(604) 559-9005
Business address
150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
  1. 4 Option exercise Chief Operating Officer acquired 250,000 shares (option exercise)
  2. 4 Open-market buy Director bought 86,938 shares at $14.02 ($1,218,871)
  3. 3 Insider Initial Statement of Ownership
  4. 4/A Option exercise Chief Operating Officer acquired 83,333 shares (option exercise)
  5. 4 Option exercise Chief Operating Officer acquired 83,333 shares (option exercise)
  6. 4 Option exercise Chief Executive Officer acquired 224,500 shares (option exercise)
  7. 4 Open-market buy Chief Financial Officer bought 67,500 shares at an average $14.71 ($993,130)
  8. 4 Open-market buy 10% owner bought 202,960 shares at $14.76 ($2,995,913)
  9. 4 Insider Changes in Ownership
  10. 4 Option exercise Director acquired 270,000 shares (option exercise)
  11. 4 Option exercise Chief Technology Officer acquired 875,000 shares (option exercise)
  12. 4 Open-market sale Director sold 300,000 shares at an average $16.94 ($5,082,253)
  13. 4 Open-market buy Director bought 6,000 shares at $17.23 ($103,380)
  14. 4 Open-market sale Director sold 100,000 shares at $25.50 ($2,550,000)
  15. 4 Other disposition Director disposed of 5,000,000 shares (other)
  16. 4 Other disposition 10% owner disposed of 5,000,000 shares (other)
  17. 4 Option exercise Chief Operating Officer acquired 333,333 shares (option exercise)
  18. 4 Open-market sale 10% owner sold 5,598,420 shares at $24.03 ($134,530,033)
  19. 4 Open-market sale Chief Executive Officer sold 6,000,000 shares at an average $24.13 ($144,770,323)
  20. 4 Open-market sale Chief Operating Officer sold 1,000,000 shares at $25.50 ($25,500,000)

Page 6 of 8 · 145 filings